StockTok Wire

StockTok’s daily headlines and financial news driving the broader market

Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences

StockTok Wire

WARREN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that it has entered into a license agreement for the development and commercialization of INOpulse® with Baylor BioSciences, a life sciences company dedicated to the

Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences Read More »

Prince Harry wins apology from Rupert Murdoch’s UK papers By Reuters

StockTok Wire

LONDON (Reuters) – Prince Harry settled his lawsuit against Rupert Murdoch’s News Group Newspapers (NGN) over alleged unlawful information gathering, his lawyer said on Wednesday. Harry’s lawyer said a deal had been struck after NGN agreed to pay significant damages and admitted Harry, younger son of Britain’s King Charles, had been the victim of unlawful

Prince Harry wins apology from Rupert Murdoch’s UK papers By Reuters Read More »

Norway’s wealth fund acquires stake in London’s Mayfair properties for $378 million By Investing.com

StockTok Wire

Investing.com — Norway’s sovereign wealth fund, managed by Norges Bank Investment Management, has purchased a 25% stake in a portfolio of office and retail properties in London’s upscale Mayfair district. The transaction was valued at approximately £306 million ($378 million). The portfolio includes about 175 buildings situated around Grosvenor Street and Mount Street. The acquisition

Norway’s wealth fund acquires stake in London’s Mayfair properties for $378 million By Investing.com Read More »

Dividend Seekers: Should You Buy Alaris Equity Stock for its 7.1% Yield?

StockTok Wire

Dividend aristocrats, those stocks with a long history of consistently increasing dividends, are excellent choices for long-term investing. The reputation for reliability stems from their ability to thrive through economic cycles, showcasing resilience and steady growth. When these stalwarts trade below their highs, it often presents a golden opportunity for investors to secure reliable income

Dividend Seekers: Should You Buy Alaris Equity Stock for its 7.1% Yield? Read More »

Here’s How Much You’d Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago

StockTok Wire

How much a stock’s price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across sectors and industries as well. Another thing that can drive investing is the fear of missing out, or FOMO. This particularly applies to

Here’s How Much You’d Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago Read More »

Subscribe
Subscribe